# FDA 483 - Robert Clark Brown, MD, PhD - August 20, 2021

Source: https://www.keypedia.com/records/483/robert-clark-brown-md-phd/7d834e70-17db-4810-9c9b-d506c20b7ad5

> FDA 483 for Robert Clark Brown, MD, PhD on August 20, 2021. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Robert Clark Brown, MD, PhD
- Inspection Date: 2021-08-20
- Product Type: drugs
- Office Name: Atlanta District Office
- Summary: An FDA inspection of Robert Clark Brown, MD, PhD in Atlanta, GA, revealed significant deficiencies in clinical investigation conduct. The firm failed to follow its investigational plan by not completing required safety laboratory assessments for a majority of enrolled subjects. Additionally, the firm did not promptly report numerous protocol deviations, including missed safety labs, to the IRB as required.

## Related Officers

- [Vanessa E. Coulter](https://www.keypedia.com/people/vanessa-e-coulter/add8407c-0df8-43ed-9f5a-8063880ce638)

Company: https://www.keypedia.com/companies/robert-clark-brown-md-phd/3cb51c5a-5479-45b8-b0ee-1f139e288d97

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7